|
CN104436183A
|
|
Method for preparing typhoid polysaccharide vaccines
|
|
CN104430301A
|
|
Method for improving survival rate of human diploid cells
|
|
CN104328163A
|
|
Detecting method for establishing boundary of generations and detecting generations of human diploid cells
|
|
CN104357536A
|
|
Method for defining cell generation time by use of large-scale bioreactor
|
|
CN104357541A
|
|
Test method for cell population doubling
|
|
CN104353068A
|
|
Large-scale production method of rabies vaccines by using human diploid cells
|
|
CN104174019A
|
|
Quadrivalent meningococcal polysaccharide carrier protein conjugate vaccine
|
|
CN103736089A
|
|
Human diploid cell cultured rabies vaccine and preparation method thereof
|
|
CN103505723A
|
|
Method for preparing freeze-dried rabies vaccine preparation
|
|
CN103550773A
|
|
Multivalent combined vaccine
|
|
CN103520716A
|
|
Preparation method for avian influenza virus split vaccine
|
|
CN102688502A
|
|
Preparation process for gene vaccines containing UreB and CagA protein of helicobacter pylori
|
|
CN102671192A
|
|
Human diploid cell rabies vaccine and preparation method thereof
|
|
CN102671194A
|
|
Human vaccine for preventing hydrophobia and tetanus
|
|
CN102406928A
|
|
Method for producing human diploid cell poliomyelitis inactivated vaccine
|
|
CN102526717A
|
|
Preparation method for absorbed acellular diphtheria, tetanus and pertussis combined vaccine
|
|
CN102406930A
|
|
Method for preparing seasonal influenza virus split vaccine
|
|
CN102406931A
|
|
Pandemic influenza virus split vaccine
|
|
CN102406933A
|
|
Preparation method for measles attenuated live vaccine
|
|
CN102614505A
|
|
Chimeric protein vaccine containing HPV16 type L1 and E7 target antigens expressed in yeast cells and its preparation method
|
